Cariprazine: Patients with Treatment-Resistant Schizophrenia

Thomas Aubel Kliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Essen, GermanyCorrespondence: Thomas AubelKliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Henricistraße 92, Essen, 45136, GermanyTel +4920117430005...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Aubel T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	cariprazine schizophrenia paranoid schizophrenia negative symptoms resistant schizophrenia antipsychotics Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/9b21135d1adb403f8c109d0cc7935cca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9b21135d1adb403f8c109d0cc7935cca
record_format	dspace
spelling	oai:doaj.org-article:9b21135d1adb403f8c109d0cc7935cca2021-12-02T16:12:38ZCariprazine: Patients with Treatment-Resistant Schizophrenia1178-2021https://doaj.org/article/9b21135d1adb403f8c109d0cc7935cca2021-07-01T00:00:00Zhttps://www.dovepress.com/cariprazine-patients-with-treatment-resistant-schizophrenia-peer-reviewed-fulltext-article-NDThttps://doaj.org/toc/1178-2021Thomas Aubel Kliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Essen, GermanyCorrespondence: Thomas AubelKliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Henricistraße 92, Essen, 45136, GermanyTel +4920117430005Email T.Aubel@kem-med.comAbstract: Schizophrenia is a chronic relapsing and remitting disorder associated with significant impairments in social and vocational functioning and a shortened lifespan, and it is a disabling psychiatric brain syndrome whose phenotype is characterized by three core symptom domains: positive symptoms, such as delusions and hallucinations, negative symptoms, which include lack of motivation and social withdrawal, and cognitive impairment. Moreover, patients with schizophrenia have severe problems with personal and social relations which affect their quality of life. Antipsychotic medications in conjunction with psychosocial interventions can help patients achieve recovery. Here are described three clinical cases of schizophrenic patients treated with cariprazine for inadequate response to a previous treatment. The purpose of this clinical series is to give useful information for the use of cariprazine in clinical practice.Keywords: cariprazine, schizophrenia, paranoid schizophrenia, negative symptoms, resistant schizophrenia, antipsychoticsAubel TDove Medical Pressarticlecariprazineschizophreniaparanoid schizophrenianegative symptomsresistant schizophreniaantipsychoticsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 2327-2332 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	cariprazine schizophrenia paranoid schizophrenia negative symptoms resistant schizophrenia antipsychotics Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	cariprazine schizophrenia paranoid schizophrenia negative symptoms resistant schizophrenia antipsychotics Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Aubel T Cariprazine: Patients with Treatment-Resistant Schizophrenia
description	Thomas Aubel Kliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Essen, GermanyCorrespondence: Thomas AubelKliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie, Psychosomatik und Suchtmedizin, Henricistraße 92, Essen, 45136, GermanyTel +4920117430005Email T.Aubel@kem-med.comAbstract: Schizophrenia is a chronic relapsing and remitting disorder associated with significant impairments in social and vocational functioning and a shortened lifespan, and it is a disabling psychiatric brain syndrome whose phenotype is characterized by three core symptom domains: positive symptoms, such as delusions and hallucinations, negative symptoms, which include lack of motivation and social withdrawal, and cognitive impairment. Moreover, patients with schizophrenia have severe problems with personal and social relations which affect their quality of life. Antipsychotic medications in conjunction with psychosocial interventions can help patients achieve recovery. Here are described three clinical cases of schizophrenic patients treated with cariprazine for inadequate response to a previous treatment. The purpose of this clinical series is to give useful information for the use of cariprazine in clinical practice.Keywords: cariprazine, schizophrenia, paranoid schizophrenia, negative symptoms, resistant schizophrenia, antipsychotics
format	article
author	Aubel T
author_facet	Aubel T
author_sort	Aubel T
title	Cariprazine: Patients with Treatment-Resistant Schizophrenia
title_short	Cariprazine: Patients with Treatment-Resistant Schizophrenia
title_full	Cariprazine: Patients with Treatment-Resistant Schizophrenia
title_fullStr	Cariprazine: Patients with Treatment-Resistant Schizophrenia
title_full_unstemmed	Cariprazine: Patients with Treatment-Resistant Schizophrenia
title_sort	cariprazine: patients with treatment-resistant schizophrenia
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/9b21135d1adb403f8c109d0cc7935cca
work_keys_str_mv	AT aubelt cariprazinepatientswithtreatmentresistantschizophrenia
_version_	1718384364787597312

Cariprazine: Patients with Treatment-Resistant Schizophrenia

Ejemplares similares